Balaxi Pharmaceuticals Limited

₹22.34As of Sun 8 Nov 2026, 12:00 UTC
NSE:BALAXIHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 21.49%
Div yield —
ROE 0.59%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.74
PE TTM 49.96
TSR TTM (47.97%)
Mkt cap ₹1.233B
ROIC 0.84%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹24
6.24%
(92.63%)
Buy 9|12|2|6|3
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.30
0.29
0.31
0.31
11.27%
11.69%
19.25%
9.05%
Revenue₹M
60.73
61.07
60.69
63.97
0.17%
(2.98%)
(4.10%)
3.14%
Peers (US$12.93M)
Cap (US$)
PE
13.93M
18.09x
12.08M
25.54x
Capital
TTM
5Y
10Y
Leveragex
0.608
0.034
0.029
EBIT/Intx
0.144
0.239
0.204
Own earn%
20.23
50.39
46.28
Sh yield%
26.78
33.04
32.01
Owners
Insiders/Inst%
5.22
25.97
Short interest%
4.15
SBC / revenue%
5.94
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
8–22
$1 testx
0.6
Incr. ROIC%
33